Your browser doesn't support javascript.
loading
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance.
He, Sijia; Ryu, Jiyoon; Liu, Juanhong; Luo, Hairong; Lv, Ying; Langlais, Paul R; Wen, Jie; Dong, Feng; Sun, Zhe; Xia, Wenjuan; Lynch, Jane L; Duggirala, Ravindranath; Nicholson, Bruce J; Zang, Mengwei; Shi, Yuguang; Zhang, Fang; Liu, Feng; Bai, Juli; Dong, Lily Q.
Affiliation
  • He S; Department of Pharmacology and.
  • Ryu J; Department of Cell Systems & Anatomy, University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Liu J; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Luo H; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Lv Y; Novo Nordisk Research Centre China, Beijing, China.
  • Langlais PR; Department of Medicine, University of Arizona, Tucson, Arizona, USA.
  • Wen J; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Dong F; Department of Biochemistry and Structural Biology, University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Sun Z; Novo Nordisk Research Centre China, Beijing, China.
  • Xia W; Novo Nordisk Research Centre China, Beijing, China.
  • Lynch JL; Department of Pediatrics, University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Duggirala R; Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas, USA.
  • Nicholson BJ; Department of Biochemistry and Structural Biology, University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Zang M; Department of Molecular Medicine, University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Shi Y; Department of Pharmacology and.
  • Zhang F; Novo Nordisk Research Centre China, Beijing, China.
  • Liu F; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Bai J; Department of Pharmacology and.
  • Dong LQ; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
J Clin Invest ; 131(24)2021 12 15.
Article in En | MEDLINE | ID: mdl-34730111
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Glycoproteins / Adipokines / Fatty Liver / Obesity Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Glycoproteins / Adipokines / Fatty Liver / Obesity Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2021 Document type: Article